课题基金 / 基金详情

项目摘要

项目成果

RAPHAEL KOPAN的其他基金

相似基金

相关文献

中文摘要
翻译
哺乳动物表达四种Notch受体旁系同源物(Notchi-4),其涉及广泛的免疫调节。 在胚胎发生、出生后发育和各种病理过程中发挥作用,包括癌症。作为 因此,人们对旨在阻断或激活特定细胞中Notch信号传导的疗法越来越感兴趣。 或病理背景。在上一个资助期内,我们探讨了 通过用结合敲入Notchi等位基因(Nl::CreLo)的新遗传方法丧失Notchi活性, 其中Cre取代了NICD和条件性Notchi靶等位基因(Niflox)。反式杂合子 将动物(N1:CreLo/flox)培育成在分子报告核心中开发的报告小鼠, 在各自的基因组中含有停止的点击甲虫红色荧光素酶和双报告基因(lac-Z或eYFP), ROSA 26基因座下游的等位基因。一个系统的,终身的体内筛选与生物发光 对发生随机、进行性和年龄依赖性Notchi丧失的动物进行成像, Notchi在抑制血管系统肿瘤方面的作用。我们的发现警告基因技术 针对Notchi的治疗方法,并提供一个模型,以评估延迟,预防和治疗Notchi的策略。 或控制血管肿瘤形成,从而拓宽抗Notch疗法的治疗窗。我们 将使用新的NI::CreERT 2等位基因检查血管肿瘤形成中的年龄、饮食和器官依赖性 允许暂时控制诺奇的死亡我们将使用另一种新的Notch反式杂合子 组合,N2::CreLo/flox,以监测与Notch 2损失相关的风险。额外 从拟议的实验中受益的将是所有干细胞区室的详细地图,Notchi 和Notch 2维持茎性或促进分化。这些研究最终将导致更安全的Notch- 靶向治疗
英文摘要
Mammals express four Notch receptor paralogs (Notchi -4) that have been implicated in a broad range of functions during embryogenesis, post-natal development, and vartous pathologies, including cancer. As a result, there is growing interest in therapies aimed at blocking or activating Notch signaling in specific cellular or pathological contexts. During the previous funding period, we explored the spectrum of effects triggered by loss of Notchi activity with a novel genetic approach combining a knock-in Notchi allele (Nl ::CreLo), in which Cre replaced the NICD, and a conditional Notchi target allele (Niflox). The trans-heterozygous animals (Nl :CreLo/flox) were bred to reporter mice developed in the Molecular Reporter Core which contained floxed-stop click beetle red luciferase and dual reporter (lac-Z or eYFP) genes on respective alleles downstream ofthe ROSA26 locus. A systematic, life-long in vivo screen with bioluminescence imaging of animals wherein a random, progressive and age-dependent Notchi loss occurred identified a role for Notchi in suppressing neoplasia ofthe vascular system. Our findings caution against the Genetech approach of therapies targeting Notchi and provide a model in which to assess strategies to delay, prevent or control vascular tumor formation and thereby widen the therapeutic window of anti-Notch therapies. We will examine age, diet and organ dependence in vascular tumor formation using new Nl ::CreERT2 alleles permitting temporal control over loss of Notchi. We will use another new Notch trans-heterozygous combination, N2::CreLo/flox, to monitor risks associated specifically with loss of Notch2. An additional benefit from the proposed experiments will be a detailed map of all stem cell compartments where Notchi and Notch2 maintain stemness or promote differentiation. These studies will ultimately lead to safer Notch- targeting therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Mechanism Regulating Renal Progenitor Aging
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS
ASSESSING THE THERAPEUTIC WINDOW FOR FUTURE ANTI-NOTCH DIMERIZATION AGENTS
2012 Notch Signaling in Development, Regeneration & Disease Gordon Conference
  • 批准号:
    8334175
  • 项目类别:
  • 资助金额:
    $1.0万
  • 财政年份:
    2012
  • 负责人:
    RAPHAEL KOPAN
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: